Home         Forums  

Go Back   Marrowforums > Bone Marrow Failure Diseases > AA
Register FAQ Search Today's Posts Mark Forums Read

AA Aplastic anemia

Reply
 
Thread Tools Search this Thread
  #1  
Old Fri Aug 10, 2012, 11:44 PM
dfantle dfantle is offline
Member
 
Join Date: Jan 2012
Location: bellevue, wa
Posts: 150
New Paper by Dr Neil Young and Dr Phillip Scheinberg

Hi everyone, below is a link to a new paper published in the Blood Journal August 9 by Dr's Young and Scheinberg at the NIH.

http://bloodjournal.hematologylibrar...1185.full.html

The paper contains really good current information on AA treatments and strategies from the 2 leading AA experts.

I thought this excerpt, towards the end of the paper & especially the bold text, was particularly interesting because I've seen a lot of postings on Marrowforums where it looks like Dr's have equated success of AA treatment or progress based on celularity of the bone marrow, but this excerpt doesn't seem to necessarily support that theory.

"How we follow SAA long term"
"Responders should be followed for late complications of relapse and clonal evolution (Figure 2). We assess for bone marrow morphology and especially karyotype at 6 and 12 months after treatment and then yearly to monitor for evolution. A hypocellular marrow should not be equated with persistent SAA or relapse in the setting of improving blood counts, as marrow cellularity often does not correlate with blood counts. Blood counts, not marrow cellularity, should guide management."


Best, Dena
__________________
Dena
Age 54; DX Heavy Chain (AH) Amyloidosis 6/10; AutoSCT 3/11; Amyloidosis remission 6/11; DX SAA 7/11; Horse ATG 3/12; Mini MUD SCT 1/13; Recovered from SAA 5/13 & feeling great

Last edited by dfantle : Sat Aug 11, 2012 at 07:23 PM.
Reply With Quote
  #2  
Old Sat Aug 11, 2012, 01:59 PM
ssdavi71416 ssdavi71416 is offline
Member
 
Join Date: Mar 2012
Location: Atlanta Georgia
Posts: 105
Smile How I treat AA.

Dena
Thank you for the post. Great information and it answers some questions. I am at 4 months post ATG and am starting to see some increases in HGB and PLT.

Scott
Reply With Quote
  #3  
Old Sat Aug 11, 2012, 02:31 PM
amberb amberb is offline
Member
 
Join Date: Aug 2011
Location: Jacksonville Beach, FL
Posts: 21
Thank you for finding and posting that article. It was refreshing to see data being proven, not just suggested. It was also nice to read about long term care, I have had difficulty finding information on that subject. I found it uplifting to read that relapse doesn't correlate with lowered survival rate, for that is still a great fear of mine.

Thank you, again.
__________________
Amber, age 24, diagnosed w/ SAA and treated w/ horse ATG 7/11, rabbit ATG 1/12, on cyclosporine. Started Desferal infusion for iron overload 7/12.
Reply With Quote
  #4  
Old Wed Aug 15, 2012, 12:37 PM
Lbrown Lbrown is offline
Member
 
Join Date: Oct 2009
Posts: 361
I find this really interesting: "marrow cellularity often does not correlate with blood counts". I wonder why.

Deb
Reply With Quote
  #5  
Old Wed Aug 15, 2012, 01:17 PM
Marlene Marlene is offline
Member
 
Join Date: Oct 2006
Location: Springfield, VA
Posts: 1,406
I don't think they ever used cellularity alone to classify aplastic anemia. I think partly because getting good consistent samples from the biopsy is difficult. The BMB is mostly needed to check for abnormal cells and to help diagnose AA vs MDS vs cancer.

To me, this paper is addressing the lack of consistency of diagnosis and treatment that happens when patients are treated by someone with little or no experience with AA. Too many times patients either run into problems that could have been avoided or even died when they are treated in a hospital where they have no experience with ATG/Cylco. On the surface, it sure seems like a pretty simple protocol but as we all know, things can wrong quickly.

And we continue to see doctor using cyclo and steroids as a first line of treatment.
__________________
Marlene, wife to John DX w/SAA April 2002, Stable partial remission; Treated with High Dose Cytoxan, Johns Hopkins, June 2002. Final phlebotomy 11/2016. As of July 2021 HGB 12.0, WBC 4.70/ANC 3.85, Plts 110K.
Reply With Quote
  #6  
Old Thu Aug 16, 2012, 12:49 AM
dfantle dfantle is offline
Member
 
Join Date: Jan 2012
Location: bellevue, wa
Posts: 150
I agree Marlene. I really liked that the paper was detailed with a lot of conclusive information, and that everything was very clear so readers don't need to have a medical background to understand it.
__________________
Dena
Age 54; DX Heavy Chain (AH) Amyloidosis 6/10; AutoSCT 3/11; Amyloidosis remission 6/11; DX SAA 7/11; Horse ATG 3/12; Mini MUD SCT 1/13; Recovered from SAA 5/13 & feeling great
Reply With Quote
Reply


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump


All times are GMT -4. The time now is 05:58 AM.


Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
Forum sites may contain non-authoritative and unverified information.
Medical decisions should be made in consultation with qualified medical professionals.
Site contents exclusive of member posts Copyright © 2006-2020 Marrowforums.org